These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28572734)

  • 1. FOLFOX regimen plus dendritic cells-cytokine-induced killer cells immunotherapy for the treatment of colorectal cancer: a meta-analysis.
    Liu Y; Zheng Z; Zhang Q; Zhou X; Feng Y; Yan A
    Onco Targets Ther; 2017; 10():2621-2633. PubMed ID: 28572734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis.
    Liu Y; Mu Y; Zhang A; Ren S; Wang W; Xie J; Zhang Y; Zhou C
    Onco Targets Ther; 2017; 10():1897-1908. PubMed ID: 28408841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced killer cells/dendritic cells-cytokine induced killer cells immunotherapy combined with chemotherapy for treatment of colorectal cancer in China: a meta-analysis of 29 trials involving 2,610 patients.
    Zhang L; Mu Y; Zhang A; Xie J; Chen S; Xu F; Wang W; Zhang Y; Ren S; Zhou C
    Oncotarget; 2017 Jul; 8(28):45164-45177. PubMed ID: 28404886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of dendritic cells-cytokine-induced killer cells mediated immunotherapy for pancreatic cancer: an up-to-date meta-analysis.
    Zhang Y; Zhang X; Zhang A; Li K; Qu K
    Onco Targets Ther; 2017; 10():4173-4192. PubMed ID: 28860827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant immunotherapy of dendritic cells and cytokine-induced killer cells is safe and enhances chemotherapy efficacy for multiple myeloma in China: a meta-analysis of clinical trials.
    Wang Y; Lv B; Li K; Zhang A; Liu H
    Drug Des Devel Ther; 2017; 11():3245-3256. PubMed ID: 29180849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effect and safety of dendritic cell-cytokine-induced killer cell immunotherapy for pancreatic cancer: a systematic review and meta-analysis.
    Liu YL; Yang LX; Zhang F; Tang BS; Zhao LT; Zhu JR; Jin QY; Wang RX; Li YM
    Cytotherapy; 2019 Oct; 21(10):1064-1080. PubMed ID: 31462394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer: A meta-analysis.
    Yuan X; Zhang AZ; Ren YL; Wang XL; Jiang CH; Yang L; Liu CX; Liang WH; Pang LJ; Gu WY; Li F; Hu JM
    Medicine (Baltimore); 2021 Apr; 100(13):e24519. PubMed ID: 33787569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and safety of chemotherapy combined with cytokine-induced killer cell /dendritic cell-cytokine-induced killer cell therapy for treatment of gastric cancer in China: A systematic review and meta-analysis.
    Mu Y; Zhou CH; Chen SF; Ding J; Zhang YX; Yang YP; Wang WH
    Cytotherapy; 2016 Sep; 18(9):1162-77. PubMed ID: 27421742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy and safety of CIK plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Liu SY; He YJ; Wang YZ; Feng JH; Yao XS; Chen L; Ma B; Yu S; Zeng XT; Li CW; Ding J
    Int Immunopharmacol; 2018 Aug; 61():363-375. PubMed ID: 29945024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effects of autologous dendritic cells combined with cytokine-induced killer cells followed by chemotherapy in treating patients with advanced colorectal cancer: a prospective study.
    Lin T; Song C; Chuo DY; Zhang H; Zhao J
    Tumour Biol; 2016 Apr; 37(4):4367-72. PubMed ID: 26499782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy and Safety of Dendritic Cells Co-Cultured with Cytokine-Induced Killer Cell Therapy in Combination with TACE-Predominant Minimally-Invasive Treatment for Hepatocellular Carcinoma: a Meta-Analysis.
    Su Y; Yang Y; Ma Y; Zhang Y; Rao W; Yang G; Kou C
    Clin Lab; 2016; 62(4):599-608. PubMed ID: 27215078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of DC-CIK cells enhances the efficacy of chemotherapy for solid cancer: a meta-analysis of randomized controlled trials in Chinese patients.
    Lan XP; Chen YG; Wang Z; Yuan CW; Wang GG; Lu GL; Mao SW; Jin XB; Xia QH
    J Zhejiang Univ Sci B; 2015 Sep; 16(9):743-56. PubMed ID: 26365116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
    Wang S; Wang Z
    Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor effects and improved immune status of dendritic cell and cytokine-induced killer cell infusion in advanced cancer patients.
    Chen F; Yang M; Song Q; Wu J; Wang X; Zhou X; Yuan Y; Song Y; Jiang N; Zhao Y; Zhou L; Ren J
    Mol Clin Oncol; 2017 Nov; 7(5):903-910. PubMed ID: 29181186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive cellular immunotherapy for the treatment of patients with breast cancer: a meta-analysis.
    Wang ZX; Cao JX; Wang M; Li D; Cui YX; Zhang XY; Liu JL; Li JL
    Cytotherapy; 2014 Jul; 16(7):934-45. PubMed ID: 24794183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer.
    Sun J; Sun Y; Miniderima ; Wang X
    Pathol Oncol Res; 2023; 29():1610710. PubMed ID: 37342361
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: a systematic review and meta-analysis.
    Chen R; Deng X; Wu H; Peng P; Wen B; Li F; Li F
    Int Immunopharmacol; 2014 Oct; 22(2):451-64. PubMed ID: 25073120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.
    Jiang N; Qiao G; Wang X; Morse MA; Gwin WR; Zhou L; Song Y; Zhao Y; Chen F; Zhou X; Huang L; Hobeika A; Yi X; Xia X; Guan Y; Song J; Ren J; Lyerly HK
    Clin Cancer Res; 2017 Sep; 23(17):5066-5073. PubMed ID: 28611200
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of cord blood-derived dendritic cells plus cytokine-induced killer cells combined with chemotherapy in the treatment of patients with advanced gastric cancer: a randomized Phase II study.
    Mu Y; Wang WH; Xie JP; Zhang YX; Yang YP; Zhou CH
    Onco Targets Ther; 2016; 9():4617-27. PubMed ID: 27524915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cytokine-induced killer cell therapy in patients with colorectal cancer: a systematic review and meta-analysis.
    Li CMY; Tomita Y; Dhakal B; Li R; Li J; Drew P; Price T; Smith E; Maddern GJ; Fenix KA
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37117007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.